Notícias

The emergence of SARS-CoV-2 variants of concern suggests viral adaptation to enhance human-to-human transmission1,2. Although much effort has focused on...

Remdesivir improves clinical outcomes in patients hospitalized with moderate-to-severe coronavirus disease 2019 (Covid-19). Whether the use of remdesivir in symptomatic,...

A ABIFINA, juntamente com outras 15 entidades da área da saúde, assina um manifesto em defesa da Agência Nacional de...

O ano de 2021 nos mostrou que, à luz da ciência, podemos enfrentar os mais difíceis obstáculos. É com essa...

A BLAU FARMACÊUTICA S.A., uma das principais indústrias farmacêuticas da América Latina focada na produção de medicamentos de alta complexidade...

The coronavirus disease 2019 (COVID-19) pandemic caused by the coronavirus—severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to cause global...

As the latest identified novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern (VOC), the influence of Omicron...

Macrodomains are a class of conserved ADP-ribosylhydrolases expressed by viruses of pandemic concern, including coronaviruses and alphaviruses. Viral macrodomains are...

A tecnologia de ProHN garante a liberação do probiótico íntegro no intestino

The Coronavirus disease 2019 (COVID-19) pandemic is one of the most devastating global problems. Regarding the lack of disease-specific treatments,...

Treatments for coronavirus disease 2019, which iscaused by severe acute respiratory syndrome coronavirus-2(SARS-CoV-2), are urgently needed but remain limited. SARSCoV-2...